Data through FY2026 Q3 (Jun 30, 2026)
Covant Therapeutics Operating Inc.
Company profile for Covant Therapeutics Operating Inc. covers 3 filings across the reporting window. FY2026 certified median offer: $260,000.
- FY2026 certified median
- $260,000
- Total filings
- 3
- FY2026 25th–75th percentile
- $260,000–$260,000
- Top job title
- Senior Director, Drug Product
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 1 | Unavailable | Unavailable | Unavailable |
| FY2025 | 1 | Unavailable | Unavailable | Unavailable |
| FY2026 (Q1–Q3) | 1 | $260,000 | $260,000 | $260,000 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Senior Director, Drug Product1 filings
- Senior Investigator, Biology1 filings
- Senior Investigator, Proteomics Platform1 filings